November 13, 2020 07:28 AM ESTUpdated 12:45 PM
Peer Review

Af­ter No­vo Nordisk's ac­qui­si­tion of Cor­vidia, Ram Ai­yar takes the helm at Ko­r­ro Bio; Sil­ver­back gets a new CFO to go along with its IPO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Co-found­ed by Nes­san Berming­ham and bank­ing $91.5 mil­lion in Se­ries A fund­ing in Sep­tem­ber, RNA edit­ing start­up Ko­r­ro Bio

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times